Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2003
12/10/2003EP1117403B1 Mglur5 antagonists for the treatment of pain and anxiety
12/10/2003EP1115721B1 Pyrimidone derivatives
12/10/2003EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases
12/10/2003EP0971885B1 Process for preparing indane-like compounds
12/10/2003EP0935598B1 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
12/10/2003EP0901374B1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
12/10/2003EP0853615B1 Piperidine compounds as calcium channel blockers
12/10/2003EP0778770B1 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
12/10/2003EP0711169B1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461308A Leucine-based motif and clostridial neurotoxins
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461222A Behavior chemotherapy
12/10/2003CN1461219A Non-sedating barbiturate compounds as neuroprotective agents
12/10/2003CN1461218A Therapeutic combination of amlodipine and benazepril
12/10/2003CN1461217A Novel uses of non-peptide bombesin receptor antagonists for treating anxiety and panic disorders
12/10/2003CN1461216A Compound for use as medicament for treatment of disorders involving bronchocontraction
12/10/2003CN1460679A Synthesis method of medicine for curing senile dementia
12/10/2003CN1460516A Chinese medicine preparation for quickly-stopping addiction and curing abstinence syndrome, its preparation method and application
12/10/2003CN1460510A Chinese patent medicine with the functions of replenishing qi and blood and nourishing the heart to calm the mind, its preparation method and quality control method
12/10/2003CN1460487A Propolis soft capsule and its preparation method
12/10/2003CN1460476A Apomorphine sublingual dripping pill preparation with adjustable medicine-releasing rate
12/10/2003CN1460469A Preparation method of aspirin microsphere
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
12/10/2003CN1130349C H3 receptor liqands of phenyl-alkyl-imidazoles type
12/10/2003CN1130221C Use of glial neurotrophic factor (GDNF) for treatment of hearing disorders
12/10/2003CN1130216C Medicine for preventing and treating radiation damage of central nervous system
12/10/2003CN1130200C Glucocorticoid receptor antagonists for treatment of dementia
12/09/2003US6660873 Method for the preparation of citalopram
12/09/2003US6660862 Genetic engineering
12/09/2003US6660859 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660769 The presence of a substituted amine functional group in the C-3 position of 2,2-dialkyl-1,4-butyrolactones leads to a greater enhancement in GABA effects
12/09/2003US6660767 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
12/09/2003US6660754 Method for reducing or eliminating smoking
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660748 1-azabicyclo(2.2.1)heptane or quinuclidine derivatives; treating or preventing neuronal damage associated with neurological diseases
12/09/2003US6660746 Cardiovascular disorders
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660737 Medicinal uses of hydrazones
12/09/2003US6660736 MAO-B inhibitors
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660729 Particle-forming compositions containing fused pyrrolocarbazoles
12/09/2003US6660725 Method and composition for modulating amyloidosis
12/09/2003US6660467 Variant of ciliary neurotrophic factor and DNA encoding the variant
12/09/2003US6660268 Proteasome regulation of NF-KB activity
12/09/2003US6659107 Sensitization of cells with porphyrins, then exposing to radiation and grafting; photodynamic therapy
12/09/2003CA2227298C Paroxetine controlled release compositions
12/09/2003CA2094457C Monoquaternary 2,16-bispiperidinylandrostane derivatives
12/09/2003CA2078758C 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
12/09/2003CA2069202C The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery
12/04/2003WO2003100435A2 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2)
12/04/2003WO2003100092A2 Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases
12/04/2003WO2003100091A1 Means and methods for improved treatment using 'setrones'
12/04/2003WO2003100087A2 Regulation of novel human asparagine-hydroxylases
12/04/2003WO2003100041A1 Cd100 semaphorin in myelination
12/04/2003WO2003099845A2 Fas peptide mimetics and uses thereof
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099836A1 C-aryl glucoside sglt2 inhibitors and method
12/04/2003WO2003099827A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099820A1 Pyrazolo-pyrimidine aniline compounds
12/04/2003WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/04/2003WO2003099818A1 Substituted quinazolinone compounds
12/04/2003WO2003099817A1 8-fluorimidazo`1,2-a!pyridine derivatives as ligands for gaba receptors
12/04/2003WO2003099816A1 Imidazo-pyridine derivatives as ligands for gaba receptors
12/04/2003WO2003099808A1 Substituted heterocyclic compounds and methods of use
12/04/2003WO2003099805A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003WO2003099797A1 Salts of bis-arylsulfones for the treatment of cns disorders
12/04/2003WO2003099796A1 Protein kinase inhibitors
12/04/2003WO2003099795A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors
12/04/2003WO2003099792A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
12/04/2003WO2003099788A1 Piperidine derivatives
12/04/2003WO2003099786A2 Aromatic sulfones and their medical use
12/04/2003WO2003099783A2 Tropane compounds
12/04/2003WO2003099781A2 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
12/04/2003WO2003099775A1 Sulfone liver x-receptor modulators
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099772A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
12/04/2003WO2003099771A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003WO2003099767A1 Amide derivatives as inhibitors of the enzymatic activity of renin
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099764A1 ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS
12/04/2003WO2003099763A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
12/04/2003WO2003099762A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/04/2003WO2003099759A1 Preparation and application of transhintotalphenolic acid
12/04/2003WO2003099337A2 Inclusion complexes of rosiglitazone
12/04/2003WO2003099326A1 Novel uses of parapoxvirus preparations
12/04/2003WO2003099318A2 Pancreas-specific proteins
12/04/2003WO2003099317A1 Novel uses of cephaibols
12/04/2003WO2003099302A1 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
12/04/2003WO2003099301A1 Formulation containing tetrodotoxin for abstinence and analgecize which is administered through respiratory tract
12/04/2003WO2003099299A1 Agents and methods for the treatment of disorders associated with motor neuron degeneration
12/04/2003WO2003099296A1 Method of treating multiple sclerosis
12/04/2003WO2003099289A2 Compositions and their uses for alleviating pain
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099280A1 Novel formulation for the parenteral application of crobenetine
1 ... 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 ... 1833